Related Experiment Videos
Physical and chemical processing for a human dura mater substitute
D Dufrane1, O Cornu, C Delloye
1University Tissue Bank, Université catholique de Louvain, Orthopaedic Research Laboratory, Brussels, Belgium. denis.dufrane@clin.ucl.ac.be
Biomaterials
|June 19, 2002
Summary
Chemically treated allogenic human fascia lata is a safe dura mater substitute. This biocompatible graft material shows no cytotoxicity and supports cell growth, offering a reliable alternative for neurosurgery.
Area of Science:
- Biomaterials science
- Neurosurgery
- Tissue engineering
Background:
- Allogenic human fascia lata is used as a dura mater substitute in neurosurgery.
- Current treatments carry a risk of viral and bacterial transmission.
- Processing methods are needed to ensure graft safety.
Purpose of the Study:
- To evaluate the biological properties of chemically and physically treated human fascia lata.
- To assess the safety and biocompatibility of fascia lata as a dura mater substitute.
Main Methods:
- Fascia lata grafts were treated with solvent detergents, freeze-dried, and gamma irradiated.
- Cytotoxicity was assessed using fibroblast cell cultures (MTT and NR assays).
- Direct cell-graft contact was evaluated using confocal laser scanning microscopy.
Main Results:
- Treated allografts showed no acute cytotoxicity.
- Human fibroblasts exhibited good growth and spreading on the graft material.
- Microscopy confirmed positive cell-graft interactions.
Conclusions:
- Secured human fascia lata is a fully biocompatible alternative for dural grafting.
- The treated graft material presents a safe option compared to existing dural substitutes.
- This biomaterial holds promise for neurosurgical applications.